Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov 1;110(11):1159-1160.
doi: 10.1093/jnci/djy038.

Reduced Risk of Prostate Cancer With 5α-Reductase Inhibitors

Ian Thompson Jr  1 , Phyllis Goodman  2 , Catherine Tangen  2
Affiliations
Editorial

Reduced Risk of Prostate Cancer With 5α-Reductase Inhibitors

Ian Thompson Jr et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A.. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. - PubMed
    1. McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Eng J Med. 2003;349(25):2387–2398. - PubMed
    1. Tosoian JJ, Carter HB, Lepor A, Loeb S.. Active surveillance for prostate cancer: Contemporary state of practice. Nat Rev Urol. 2016;13(4):205–215. - PMC - PubMed
    1. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of followup. Lancet. 2014;384(9959):2027–2035. - PMC - PubMed
    1. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215–224. - PubMed

Substances